15 Stocks Moving In Monday's After-Hours Session

Gainers

• Arista Networks ANET shares are trading higher after the company reported better-than-expected Q3 EPS and sales results. The company also issued Q4 sales guidance below estimates.
• Halozyme Therapeutics HALO shares are trading higher after the company reported better-than-expected Q3 EPS and sales results. The company also raised FY20 EPS and sales guidance above estimates.
• Inspire Medical Systems INSP shares are trading higher after the company reported better-than-expected Q3 EPS and sales results.
• Jazz Pharmaceuticals JAZZ shares are trading higher after the company reported better-than-expected Q3 EPS and sales results. The company also raised FY20 sales guidance above estimates.
• Karyopharm Therapeutics KPTI shares are trading higher after the company announced the Phase 3 SEAL study met its primary endpoint.
• Medifast MED shares are trading higher after the company reported better-than-expected Q3 EPS and sales results.
• Jakks Pacific JAKK shares are trading higher after the company reported better-than-expected Q3 EPS and sales results.
• Infrastructure And Energy Alternatives IEA shares are trading higher after the company reported a $550 million joint venture with FH Paschen for West Lake Corridor rail expansion in Indiana.

Losers

• SolarEdge Technologies SEDG shares are trading lower after the company reported worse-than-expected Q3 sales results. The company also issued Q4 sales guidance below estimates.
• Enphase Energy ENPH shares are trading lower in sympathy with SolarEdge Technologies after the company reported worse-than-expected Q3 sales results and issued Q4 sales guidance below estimates.
• Coupa Software COUP shares are trading lower after the company announced a proposed public offering of roughly 2.1 million shares of common stock by selling shareholders.
• Pacific Biosciences of California PACB shares are trading lower after the company reported worse-than-expected Q3 EPS results.
• Bruker BRKR shares are trading lower after the company reported Q3 earnings results. It said it expects the pandemic and economic slowdown will continue to have a negative year-over-year impact on its Q4 results.
• Aurinia Pharmaceuticals AUPH shares are trading lower after the company reported its AUDREY trial in dry eye syndrome did not achieve statistical significance on its primary endpoint.
• Durect DRRX shares are trading lower after the company reported worse-than-expected Q3 EPS and sales results.